Iscom is an efficient mucosal delivery system for Mycoplasma mycoides subsp. mycoides (MmmSC) antigens inducing high mucosal and systemic antibody responses

FEMS Immunology and Medical Microbiology

Volumn 23, Issue 1, 1999, Pages 5-12

  Abusugra, Izzeldin ^a   Morein, Bror ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Antibody dose response; Immunoglobulin A in lung and serum; Immunoglobulin G subclass; Mucosal and systemic immune response; Mycoplasma mycoides cells and iscoms after intranasal and subcutaneous immunization; Western blot

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; ISCOM;

ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; FEMALE; HUMAN TISSUE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INTRANASAL DRUG ADMINISTRATION; LUNG PARENCHYMA; MOUSE; MYCOPLASMA MYCOIDES; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; ISCOMS; LUNG; MICE; MICE, INBRED BALB C; MYCOPLASMA MYCOIDES; VACCINATION;

EID: 0032972467     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(98)00111-4     Document Type: Article

References (33)

1. Hudson, J.R. (1965) Contagious bovine pleuropneumonia: The immunizing value of the attenuated strain KH3J. Aust. Vet. J. 41, 43-49
2. Provost, A., Perreau, P., Breard, A., Le Goff, C., Martel, J.L. and Cottew, G.S. (1987) Contagious bovine pleuropneumonia. Rev. Sci. Tech. Off. Int. Epiz. 6, 625-679.
3. Gray, M.A., Simam, P.K. and Smith, G.R. (1986) Observations on experimental inactivated vaccines for contagious bovine pleuropneumonia. J. Hyg. Camb. 97, 305-315.
4. Karst, O. (1971) Contagious bovine pleuropneumonia: Lyophilised (T1) vaccine. Res. Vet. Sci. 12, 18-22.
5. Howard, C.J. and Taylor, G. (1985) Humoral and cell mediated immunity. In: The Mycoplasmas, Vol. 4. Mycoplasma Pathogenicity (Rasin, S. and Barile, M.F., Eds.), pp. 259-292. Academic Press, Orlando, FL.
6. Masiga, W.N. and Domenech. J. (1995) Overview and epidemiology of contagious bovine pleuropneumonia in Africa. Rev. Sci. Tech. Off.Int. Epiz. 14, 611-620.
7. Tulasne, J.J., Litamoi, J.K., Morein, B., Dedieu, L., Palya, V.J., Yami, M., Abusugra, I., Sylla, D. and Bensaid, A. (1996) Contagious bovine pleuropneumonia vaccines: The current situation and the need for improvement. Rev. Sci. Tech. Off. Int. Epiz. 15, 1372-1396.
8. Morein, B., Lövgren-Bengtsson, K. and Cox, J. (1996) Modern adjuvants: Functional aspects. In: Concepts in Vaccine Development (Kaufmann, S.H.E., Ed.), pp. 243-263. Walter de Gruyter, Berlin.
9. Bradford, M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principals of protein-dye binding. Anal. Biochem. 72, 248-254.
10. Abusugra, I., Wolf, G., Bölske, G., Thiaucourt, F. and Morein, B. (1997) ISCOM vaccine against contagious bovine pleuropneumonia (CBPP) I. Biochemical and immunological characterization. Vet. Immunol. Immunopathol. 59, 31-48.
11. Morein, B., Sundqvist, B., Höglund, S., Dalsgaard. K. and Osterhaus, A. (1984) Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308, 457-460.
12. Lövgren, K. and Morein, B. (1988) The requirement of lipids for the construction of immunostimulating complexes (iscoms). Biotechnol. Appl. Biochem. 10, 161-172.
13. Bergquist, C., Lagergård, T., Lindblad, M. and Holmgren, J. (1995) Local and systemic antibody responses to dextran-cholera toxins B subunit conjugates. Infect. Immun. 63, 2021-2025.
14. Hu, K.F., Morein, B. and Merza, M. (1998) Using distilled water for the extraction of mucosal antibodies and the subsequent application in RSV neutralization test. J. Immunoassay 19, 209-222.
15. Voller, A., Bartlett. A. and Bidwell, D.E. (1978) The use of enzyme linked immunosorbent assay in the serology of viral and parasitic diseases. Scand. J. Immunol. 8, 123-129.
16. Towbin, H., Staehelin, T. and Gordin, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets; Procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
17. Morein, B., Lövgren, K., Rönberg, B., Sjölander, A. and Villacres-Eriksson, M. (1995) Immunostimulating complexes: Clinical potential in vaccine development. Clin. Immunother. 3, 461-475.
18. Villacres-Eriksson, M. (1995) Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes. Clin. Exp. Immunol. 102, 46-52.
19. Heeney, J.L., Gills, M., Teeuwsen, V.J.P., Bogers, W.M.J.M., Morghen, C.G., Radaelli, A., Barnett, S., Morein, B., Åkerblom, L., Wang, Y., Lehner, T. and Davis, D. (1998) Proc. Natl. Acad. Sci. USA (in press).
20. Hu, K.F., Elvander, M., Merza, M., Åkerblom, L., Brandenberg, A. and Morein, B. (1998) The immunostimulating complex (ISCOM) is an efficient delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses. Clin. Exp. Immunol. 113, 235-243.
21. Vetter, R.A., Lehrer, S., Ramphal, R. and Small Jr., P.A. (1980) Outcome of influenza infection: Effect of site of initial infection and heterotypic immunity. Infect. Immun. 29, 654-662.
22. Raghupathy, R. (1997) Th1-type immunity is incompatible with successful pregnancy. Immunol. Today 10, 478-482.
23. Lazzell, V., Waldman, R.H., Rose, C., Khakoo, R., Jacknowitz, A. and Howard, S. (1984) Immunization against influenza in humans using an oral enteric-coated killed virus vaccine. J. Biol. Stand. 12, 315-321.
24. Bergmann, K.-Ch., Waldmann, R.H., Tischner, H. and Pohl, W.D. (1986) Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccines. Int. Arch. Allergy Appl. Immunol. 80, 107.
25. Holmgren, J., Czekinsky, C., Lycke, N. and Svennerholm, A.-M. (1994) Strategies for the induction of the immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier and adjuvant. Am. J. Trop. Med. Hyg. 50, Suppl., 42-54.
26. Chong, C., Friberg, M. and Clements, J.D. (1998) LT (R192G), a non-toxic mutant of the heat-labile enterotoxin of escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp. Vaccine 16, 732-740.
27. Giuliani, M.M., Del Giudice, G., Giannelli, V., Dougan, G., Douce, G., Rappuoli, R. and Pizza, M. (1998) Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J. Exp. Med. 187, 1123-1132.
28. Mowat, A.McL. and Maloy, K.J. (1994) Immune stimulating complexes as vectors for oral immunization. In: Novel Delivery Systems for Oral Vaccines (O'Hagan, D.T., Ed.), Chapter 3. CRC Press, Boca Raton, FL.
29. Smith, R.E., Donachie, A.M., McLaren, F.H. and Mowat, A.McL. (1988) Preservation of mucosal and systemic adjuvant properties of iscoms in the absence of functional interleukin-4 or interferon-γ. Immunology 93, 556-562.
30. Ogra, P.L., Fishaut, M. and Gallagher, M.R. (1980) Viral vaccination via the mucosal routes. Rev. Infect. Dis. 2, 352-369.
31. Carol. H., Nieto, A., Villacres-Eriksson, M. and Morein, B. (1997) Intranasal immunization of mice with Echinococcus granulosus surface antigens iscoms evokes a strong immune response, biased towards glucidic epitopes. Parasite Immunol. 19, 197-205.
32. Porcelli, S.A., Segelke, B.W., Sugita, M., Wilson, I.A. and Brenner, M.B. (1998) The CDl family of lipid antigen-presenting molecules. Immunol. Today 19, 362-368.
33. Rhalem, A., Sahibi, H., Dakkak, A., Laurent, F., Kazanji, M., Yvore, P. and Péry, P. (1993) Protective oral immunization of chickens against Eimeria tenella with sporozoite surface antigens. Vet. Immunol. Immunopathol. 38, 327-349.